Antonio Alcaraz

ARCHES: A Randomized, Phase III Study of Androgen Deprivation Therapy With Enzalutamide or Placebo in Men With Metastatic Hormone-Sensitive Prostate Cancer

Andrew J. Armstrong, Russell Z. Szmulewitz, Daniel P. Petrylak et al. · Journal of Clinical Oncology · 2019 · 1.2K citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial

Abdel-Rahmène Azzouzi, S. Vincendeau, Éric Barret et al. · The Lancet Oncology · 2016 · 330 citations

Medicine, Oncology, Pharmacology +15

Improved Survival With Enzalutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer

Andrew J. Armstrong, Arun Azad, Taro Iguchi et al. · Journal of Clinical Oncology · 2022 · 299 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

MULTIVARIATE ANALYSIS OF CLINICAL PARAMETERS OF SYNCHRONOUS PRIMARY SUPERFICIAL BLADDER CANCER AND UPPER URINARY TRACT TUMOR

Juan Palou, F Rodríguez-Rubio, J. Huguet et al. · The Journal of Urology · 2005 · 157 citations

Medicine, Oncology, Urology +13

Normothermic recirculation reduces primary graft dysfunction of kidneys obtained from non-heart-beating donors

R. Valero, C Cabrer, F. Oppenheimer et al. · Transplant International · 2000 · 155 citations

Medicine, Nephrology, Surgery +10